These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1290801)

  • 61. Effects of glucose-dependent insulinotropic peptide on osteoclast function.
    Zhong Q; Itokawa T; Sridhar S; Ding KH; Xie D; Kang B; Bollag WB; Bollag RJ; Hamrick M; Insogna K; Isales CM
    Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E543-8. PubMed ID: 17003233
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of membrane potential on surface Ca2+ receptor activation in rat osteoclasts.
    Shankar VS; Huang CL; Adebanjo O; Simon B; Alam AS; Moonga BS; Pazianas M; Scott RH; Zaidi M
    J Cell Physiol; 1995 Jan; 162(1):1-8. PubMed ID: 7814441
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hydroxychloroquine affects bone resorption both in vitro and in vivo.
    Both T; Zillikens MC; Schreuders-Koedam M; Vis M; Lam WK; Weel AEAM; van Leeuwen JPTM; van Hagen PM; van der Eerden BCJ; van Daele PLA
    J Cell Physiol; 2018 Feb; 233(2):1424-1433. PubMed ID: 28556961
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis.
    Hirayama T; Danks L; Sabokbar A; Athanasou NA
    Rheumatology (Oxford); 2002 Nov; 41(11):1232-9. PubMed ID: 12421995
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A novel synthetic triazolotriazepine derivative JTT-606 inhibits bone resorption by down-regulation of action and production of bone resorptive factors.
    Chikazu D; Shindo M; Iwasaka T; Katagiri M; Manabe N; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2000 Apr; 15(4):674-82. PubMed ID: 10780859
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
    Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
    J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mode of action of interleukin-6 on mature osteoclasts. Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption.
    Adebanjo OA; Moonga BS; Yamate T; Sun L; Minkin C; Abe E; Zaidi M
    J Cell Biol; 1998 Sep; 142(5):1347-56. PubMed ID: 9732294
    [TBL] [Abstract][Full Text] [Related]  

  • 68. SNX10 is required for osteoclast formation and resorption activity.
    Zhu CH; Morse LR; Battaglino RA
    J Cell Biochem; 2012 May; 113(5):1608-15. PubMed ID: 22174188
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mechanism of osteoclast mediated bone resorption.
    Väänänen HK; Hentunen T; Lakkakorpi P; Parvinen EK; Sundqvist K; Tuukkanen J
    Ann Chir Gynaecol; 1988; 77(5-6):193-6. PubMed ID: 3076045
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The cellular actions of interleukin-11 on bone resorption in vitro.
    Hill PA; Tumber A; Papaioannou S; Meikle MC
    Endocrinology; 1998 Apr; 139(4):1564-72. PubMed ID: 9528935
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Regulation of osteoclast activity: a new approach in the therapy of bone diseases].
    Vanhara P; Smarda J
    Cas Lek Cesk; 2006; 145(8):606-10. PubMed ID: 16995415
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Low NO concentrations inhibit osteoclast formation in mouse marrow cultures by cGMP-dependent mechanism.
    Holliday LS; Dean AD; Lin RH; Greenwald JE; Gluck SL
    Am J Physiol; 1997 Mar; 272(3 Pt 2):F283-91. PubMed ID: 9087669
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
    Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
    Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
    Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
    J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stimulation of bone resorption and osteoclast clear zone formation by low pH: a time-course study.
    Murrills RJ; Stein LS; Dempster DW
    J Cell Physiol; 1993 Mar; 154(3):511-8. PubMed ID: 8436600
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nitric oxide: a cytokine-induced regulator of bone resorption.
    Ralston SH; Ho LP; Helfrich MH; Grabowski PS; Johnston PW; Benjamin N
    J Bone Miner Res; 1995 Jul; 10(7):1040-9. PubMed ID: 7484279
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Calcium-containing crystals enhance receptor activator of nuclear factor κB ligand/macrophage colony-stimulating factor-mediated osteoclastogenesis via extracellular-signal-regulated kinase and p38 pathways.
    Chang CC; Tsai YH; Liu Y; Lin SY; Liang YC
    Rheumatology (Oxford); 2015 Oct; 54(10):1913-22. PubMed ID: 25998451
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Strontium substitution in apatitic CaP cements effectively attenuates osteoclastic resorption but does not inhibit osteoclastogenesis.
    Schumacher M; Wagner AS; Kokesch-Himmelreich J; Bernhardt A; Rohnke M; Wenisch S; Gelinsky M
    Acta Biomater; 2016 Jun; 37():184-94. PubMed ID: 27084107
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Systemic osteoclast activation by localized pressure.
    Wolfman DE; Tinling SP
    Arch Otolaryngol Head Neck Surg; 1993 Feb; 119(2):165-8. PubMed ID: 8427678
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Local control of osteoclast function.
    Mundy GR
    Osteoporos Int; 1993; 3 Suppl 1():126-7. PubMed ID: 8461538
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.